Insights on Drug Pricing and Healthcare Policies from Health Affairs
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
The first year of the ACO program aimed at enhancing equity and community health has shown promising results, according to Health Affairs.
A recent analysis explores how changing patient cost-sharing practices are affecting the financial stability of both urban and rural hospitals.
A recent study highlights a notable decline in hospital utilization in Maryland, showing an 11 percentage point decrease compared to other states from 2013 to 2023.
A recent analysis highlights the trends in national spending on mental health and substance use disorder treatment from 2000 to 2021, reflecting case growth over the years.
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
In a recent directive, Trump has called on federal agencies to expedite access to psychedelic treatments and reconsider their classification as controlled substances.
The podcast 'Why Should I Trust You?' emphasizes the need for communication between MAHA and public health, highlighting the stakes involved.
While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.
A recent analysis reveals trends in employer-based health insurance, affecting 165.6 million individuals under 65 years old as of March 2025.
In a recent update, Truist has adjusted its outlook for Community Health Systems, Inc. as part of a broader review of the healthcare sector.
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
As cyberattacks on health care systems escalate, the potential for patient harm grows. Andrea Downing highlights the urgent need for improved defenses against these threats.
Recent updates on MAHA highlight a significant breakthrough in Duchenne muscular dystrophy, alongside ongoing challenges in cancer treatment and other health developments.
A mother's determination has reignited interest in a neglected class of drugs, potentially benefiting her son and many others with neuromuscular disorders.
Strategic angle: Researchers at NUS develop a molecular tool to study Piezo1 protein activation under mechanical force.
Strategic angle: Access to nutritious food has been historically unequal, with meat being a coveted resource in pre-industrial Europe.
Strategic angle: What it means for your health care
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.